Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Guggenheim 

BioMarin Pharmaceutical Inc. diskutieren

BioMarin Pharmaceutical Inc.

WKN: 924801 / Symbol: BMRN / Name: BioMarin Pharmaceutical / Aktie / Pharmazeutika / Large Cap /

46,35 €
0,96 %

Einschätzung Buy
Rendite (%) -11,07 %
Kursziel 73,15
Veränderung
Endet am 11.03.27

BioMarin Pharmaceutical (BMRN) had its price target lowered by Bank of America Corporation from $97.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat

BioMarin Pharmaceutical (BMRN) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Ratings data for BMRN provided by MarketBeat

BioMarin Pharmaceutical (BMRN) had its "outperform" rating reaffirmed by Wolfe Research.
Ratings data for BMRN provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,96 %
Kursziel 102,34
Veränderung
Endet am 27.04.27

BioMarin Pharmaceutical (BMRN) is now covered by Morgan Stanley. They set an "overweight" rating and a $120.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat